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Appendix
Study Cores: Institution (Core Director)
Data Coordination Center and Surgical Core: Baylor
College of Medicine (J. S. Coselli, Study Principal Investi-
gator)
Marfan Diagnostic Core: Johns Hopkins Hospital (H.
C. Dietz)
ImagingCore:Mayo Clinic, Rochester (H.M. Connolly)
Genetic Repository: University of Texas Medical
School at Houston (D. M. Milewicz)
Participating Study Sites: Institution (Site Principal
Investigator, Number of Patients Enrolled)
Argentina: Institute of Cardiology and Cardiovascular
Surgery—Favaloro Foundation (R. R. Favaloro, 10 pa-
tients).
Canada:University of Ottawa Heart Institute (K-L. Chan,
1 patient).
Germany: Hannover Medical School (A. Haverich, 5 pa-
tients); University Clinic of Schleswig-Holstein (H. H. Si-
evers, 6 patients); University of Leipzig (F. W. Mohr, 14
patients).
Netherlands: Leiden UniversityMedical Center (M. I. M.
Versteegh, 1 patient).
USA: Baylor College of Medicine (J. S. Coselli, 8 pa-
tients); Central Maine Heart and Vascular Institute (R. P. Co-
chran, C. Frumiento, 1 patient); Johns Hopkins Hospital (V.
L. Gott, L. A. Vricella, 16 patients); Loyola University Med-
ical Center (J. P. Schwartz, 3 patients);Mayo Clinic, Roches-
ter (T. M. Sundt III, 21 patients); Missouri Baptist Medical
Center (N. T. Kouchoukos, 5 patients); Montefiore Medical
Center (A. DeAnda, 2 patients); New York Presbyterian–
Cornell Hospital (L. N. Girardi, 7 patients); Northwestern
University Feinberg School of Medicine (T. G. Gleason, C.
Malaisrie, 2 patients); Stanford University (D. C. Miller, 19
patients); University of Pennsylvania (J. E. Bavaria, 19 pa-
tients); Washington University (M. R. Moon, 11 patients).




Dr Alan D. Hilgenberg (Boston, Mass). Dr Coselli, congratula-
tions to you and your colleagues for designing and implementing this
very important study. The presentation is a report of the current prac-
tice of aortic root repair in patients withMFS from centers in Europe
and North and South America. First of all, it is remarkable that there
was no 30–day mortality in 151 patients, attesting to the safety of
these complex surgical procedures. Seventy percent of the operations648 The Journal of Thoracic and Cardiovascular Sur24. Kallenbach K, Baraki H, Khaladj N, Kamiya H, Hagl C, Haverich A, et al. Aortic
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were valve-sparing, all but two of them were of the reimplantation
type, and about two thirds included repair with sinuses.
The patients undergoing AVR were different from those under-
going AVS in several important characteristics. They were older,
they had more preoperative aortic regurgitation, and they under-
went more nonelective operations. These factors probably will af-
fect the long–term results in addition to the presence of
a mechanical valve when comparisons with the outcomes of
AVS patients are made.
The most important information from this study will come from
the years of follow-up data that we hope you will accumulate. The
late results of composite valve graft replacement in patients with
MFS have been reported at least a couple of times in the last several
years. Survival at 10 years of 75% was reported by Gott in the New
England Journal of Medicine study in 1999. More recent data from
Hopkins presented at the Society of Thoracic Surgeons meeting in
2008 by Cameron had an 85% survival at 10 years. Although these
results are good, I suspect that the late results in terms of survival
and freedom from thromboembolism in the AVS group will be
even better in this study. However, how durable will the AVS op-
erations be in terms of avoiding late operation for aortic regurgita-
tion? David and Feindel reported freedom from moderate or severe
aortic insufficiency in reimplantation procedures to be 94% at 10
years, and in their studies, MFS was not a risk factor for late aortic
insufficiency. This study should be able to show whether other sur-
geons throughout the world can achieve similar results. I hope that
you will keep gathering this important follow-up data.
I have a couple of questions. Have the participating centers
agreed to include their entire experience with consecutive MFS
patients, and if not, do you think this will make a difference in
the outcomes?
Dr Coselli. They have agreed, and I do believe that not enrolling
consecutive patients would affect the results. The intent has been
that once investigators agreed to participate in the study, they
would recruit and screen consecutive patients. I believe that, so
far, compliance has been very good and consecutive patients
have been screened.
Dr Hilgenberg. I think that would be important. I am assuming
that AVS repair is the preferred operation in all of the centers. What
are the common reasons that valves were replaced, if you know,
and were there situations in which valves might have been spared
if the patient had been referred earlier for surgery?
DrCoselli. Those are good questions. In 43% of the patients, the
decision as to which operation to perform was ultimately made at
the time of surgery; the decision to replace the valve was made
by the surgeon, and it primarily revolved around anatomic features
that the surgeons, who are all well-versed in valve-sparing tech-
niques, believed would compromise the durability of a valve-spar-
ing repair.gery c March 2009
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DThere were also some patients whose primary concern was that
they did not want to have a second procedure and did not want to
subject themselves to the risks of the potential lack of durability
of the procedure; these patient selected having a mechanical valve
at the outset.
Dr Hilgenberg. David and Feindel perform cusp repair fre-
quently in these operations, and I think it would be of interest to
the audience to know whether cusp repair was used often or rarely
in this series of patients.
Dr Coselli. In this series of patients, relatively rarely; only 17%
of the patients had cusp repair.
DrHilgenberg.Onefinal comment: I amsitting herewithmycol-
league, Cary Akins, who formulates the reporting of valve-related
complications, and I think the re–exploration for bleeding in this se-
ries really does not belong in the valve-related complications. That is
a surgical complication, not necessarily valve-related, I believe.
Dr Tirone E. David (Toronto, Ontario, Canada). I am sorry
that I am not participating in this study. I think it is important to
have information regarding the aortic cusps in this database. In
my experience with AVS procedures during the past 19 years,
what determines whether a valve can be spared or not is the quality
of the aortic cusps. In at least half of my patients with MFS, I had to
repair the cusps to spare the valve. In other words, these patientsThe Journal of Thoracic and Chad premature cusp degeneration just as in mitral valve prolapse.
Unless you do something with the cusps, I am surprised that you
ended up with no aortic insufficiency. Do you have data on how
many cusps were abnormal?
Dr Coselli. In the way you describe it, no.
Dr David. I propose that you add this to the database. We find it
the single most important determinant of feasibility of repairing
these valves. Cusps with large stress fenestrations, overstretched
and thinned out, should not be preserved and AVR probably results
in better outcomes.
Dr Coselli. Dr David, thank you for your comments and thank
you for your immense contribution and pioneering work in this
area. All of the centers that participated involved surgeons who
are well-versed in the techniques and carry on a practice that allows
them to very reliably carry out AVS procedures; I believe that the
results, with no deaths, no strokes, and no moderate or severe aortic
valve regurgitation in the early postoperative period, confirm their
levels of expertise. I think it would be challenging for this type of
registry—which already collects an immense amount of data from
very diverse institutions across the globe—to accumulate the kind
of detailed information on the leaflets that a single surgeon and
a single center can. But I appreciate the insight, and ideally we
can incorporate that.ardiovascular Surgery c Volume 137, Number 3 649
